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Background: Although the general assumption is that patients with rheumatoid arthritis (RA) have decreased levels
of physical activity, no review has addressed whether this assumption is correct.
Methods: Our objective was to systematically review the literature for physical activity levels and aerobic capacity
(VO2max). in patients with (RA), compared to healthy controls and a reference population. Studies investigating
physical activity, energy expenditure or aerobic capacity in patients with RA were included. Twelve studies met
our inclusion criteria.
Results: In one study that used doubly labeled water, the gold standard measure, physical activity energy
expenditure of patients with RA was significantly decreased. Five studies examined aerobic capacity. Contradictory
evidence was found that patients with RA have lower VO2max than controls, but when compared to normative
values, patients scored below the 10th percentile. In general, it appears that patients with RA spend more time in
light and moderate activities and less in vigorous activities than controls.
Conclusion: Patients with RA appear to have significantly decreased energy expenditure, very low aerobic capacity
compared to normative values and spend less time in vigorous activities than controls.
Keywords: Rheumatoid arthritis, Cardiovascular disease, Physical activity, Aerobic capacity, Healthy controlsBackground
Rheumatoid arthritis (RA) is a chronic inflammatory dis-
ease characterised by polyarthritis and erosive synovitis
and is associated with progressive impairments and ac-
tivity limitations [1,2]. According to the recent EULAR
evidence-based recommendations for cardiovascular risk
management in patients with rheumatoid arthritis and
other forms of inflammatory arthritis [3], RA should
be regarded as a condition associated with higher risk
for cardiovascular disease (CVD). The increased risk
appears to be due to both an increased prevalence of
traditional risk factors and the inflammatory burden of
RA [4]. Adequate control of disease activity is necessary
to lower the CVD risk and evaluating the effect of* Correspondence: harriet.wittink@hu.nl
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distribution, and reproduction in any mediumlifestyle modification on the CVD risk in inflammatory
arthritis was added to the future research agenda [3].
One potentially modifiable lifestyle factor is physical
activity (PA). Exercise restrictions, traditionally given to
patients with RA because of concerns about aggravating
joint inflammation and accelerating joint damage, may
contribute to inactivity and deconditioning which is
associated with a loss of aerobic capacity [5]. In addition,
pain and depression associated with the disease, may re-
sult in low PA [6]. Inactivity has been shown to be asso-
ciated with loss of lean mass, increases in fat mass and
metabolic syndrome [6,7], contributing to CVD risk.
Several studies do show that physically inactive patients
with RA have a significantly worse CVD risk profile
compared with physically active patients [8,9]. Con-
versely, patients with RA with high levels of physical
activity (PA) (mean 3342 METhours/week) were shown
to have a significantly better CVD risk profile than those
with low levels of PA (mean 249 METhours/week), evenentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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severity and steroid use [10]. Recent research also
shows that a moderately high or high aerobic capacity,
but not high physical activity reduces metabolic
syndrome and thus CVD and DM II risk even in obese
persons [7].
Little is known about the level of daily PA among
persons with RA. For instance, a recent meta-analysis on
cardiorespiratory (aerobic) exercise in RA did not exam-
ine the influence of baseline physical activity as a con-
founder on either outcomes or statistical heterogeneity,
as this parameter was seldom reported [11]. What is
known about PA in patients with RA seems contradict-
ory. Several studies found the proportion of patients
with RA meeting national recommendations for PA
similar to those of the general population [12-14] or to
healthy women the same age [9]. A large international
study, however, reported that the majority of patients
with RA are inactive [15]. A recent systematic review on
physical activity in RA concluded that methodological
considerations within the reviewed studies prohibited
definitive conclusions on the PA levels in this population
[16]. The authors used publications on PA and energy
expenditure in patients with RA (N=16) only, including
studies that did not use a control group (N=9). The aim
of this review did not include gathering evidence on
aerobic capacity.
Data on aerobic capacity in patients with RA are hard
to find. Aerobic capacity in patients with RA aged 20–
65 years was found similar to normative data for the
same age groups from a representative sample of the
Swedish population [12], but low aerobic capacity is also
reported [17]. In this study therefore, we aimed to
explore whether individuals with RA are less physically
active and experience a decreased aerobic capacity, com-
pared to healthy controls. In addition, we used a healthy
reference population [18] to determine the percentile of
aerobic capacity for individuals with RA as healthy controls
might not be representative of the general population.Methods
Literature search
Electronic databases Medline, Cinahl, Embase, Cochrane
and PsycINFO were systematically searched up to No-
vember 2010 using the following Mesh terms and text
words: (motor activity OR leisure activities OR human
activities OR activities of daily living OR aerobic capacity
OR energy expenditure) AND rheumatoid arthritis AND
healthy, to find studies comparing patients with RA to
healthy persons. In order to limit results to adults, the
restriction NOT (child OR adolescent) was added. Refer-
ence lists from included studies were searched manually
for additional relevant studies.Inclusion criteria
Studies were included for review when following criteria
were met.
 the target population: adults with RA (18 years
and older)
 outcome measures: physical activity, energy
expenditure or aerobic capacity
 at baseline the outcome measures were compared to
those of healthy controls and values and measures
of variability were described
Exclusion criteria
 single case reports
 studies describing a direct post operative situation
 studies written in any language other than English,
German or Dutch
Using the above mentioned criteria, a researcher (TM)
reviewed the titles of articles in the search printouts
from the databases. Abstracts from potentially relevant
studies were read and included when all criteria were
met. After full text reading articles were finally included
when all afore mentioned criteria were met. A manual
search of references from included studies was con-
ducted to retrieve further potentially relevant studies.
Assessing trial characteristics and outcome data
The following information was systematically extracted
by reviewers TM and HW: type of study, number of
participating patients with RA, sex, age, setting, body
composition, disease duration, classification of impair-
ment, use of medicines and outcome measures. Based on
consensus, extracted data were included in the review.
Quality assessment of studies
Although a commonly accepted valid rating instrument
concerning the quality assessment of observational stud-
ies does not yet exist, there appears to be consensus
about important items [19-21]. This review focuses
on differences between persons with RA and healthy
controls. A comparison of patients and controls at base-
line was used in the case of intervention studies. This
resulted in the following assessment items: selection of
patients and controls, sample size calculation, adjust-
ment for confounding, blinding of assessors and use of
statistical analysis.
Results
The literature search yielded 152 studies, from which
nine double hits were excluded. Another 48 studies
were excluded based on the title. Eighty-two studies
were excluded based on abstracts. Thirteen studies were
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exclusion of another article because no data concerning
afore mentioned outcome measures was given. Refer-
ences tracking of the included studies did not yield new
studies. Finally 12 studies were included. Results of the
literature search and reasons for exclusion are depicted
in Figure 1.
Quality assessment
The included studies were all observational studies: ten
cross-sectional studies and two cohort studies. Six studies
included small groups of patients [22-27], sample size
varied from 8 to 35 patients. In six other studies
[13,14,28-31] sample size ranged from 67 to 232 patients.
In seven studies [14,22,24-27,30] samples of patients
and controls were of equal size, in the remaining 5 stud-
ies group sizes differed significantly [13,23,28,29,31]. The
majority of the patients were recruited from rheumatol-
ogy or arthritis clinics, in one study from a rehabilitation
centre [24] and in two studies [28,29] the recruitment
method was unclear. No information on the recruit-
ment of controls was available in six of the studies
[22,24-27,29]. In four studies healthy persons living in
the same area were recruited [14,22,28,30], in one
study healthy relatives acted as controls [31] and one
study used information from the general Dutch popu-




Double hit                                9 









No healthy controls               55
No data on outcome             26
Language                               1 
Articles excluded
n = 1
No data on outcome                1   
Figure 1 Flow chart literature search.Information about matching of patients and controls
was reported in nine studies [22-24,26-31]. Different
combinations of the following factors were used: race
[26,27], age [22-24,26-28,30], gender [22,24,26,28,30]
and body composition [22,26,27]. In one study groups
were matched based on genetic and ethnic variables
[31]. Having a sedentary lifestyle was a matching criter-
ion in three [22,24,25] of the five studies [22-25,28]
investigating aerobic capacity. Physically active partici-
pants were included in one study [23], whereas another
study included controls to contrast with patients in
terms of level of PA and body composition [29].
Three studies reported conducting sample size calcula-
tions [13,24,27]. Sample sizes were inadequate with
regard to statistical analysis in two cases [13,24] and in
the third study [27] adequacy of the sample size was not
reported. None of the studies reported blinding of asses-
sors. Six studies [22,24-27,31] reported that data were
tested for the assumptions for parametric statistical tests
or justified the use of non-parametric tests.
Patient characteristics
All patients met ACR criteria for RA [32]. Classification
into Functional Class (FC) I – IV (mild to severe impair-
ment) [33] was used in seven studies. In two studies
patients were classified as FC II [24,28], in five studies
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dominantly female participants were included, with per-
centages ranging from 62,5% to 88,6%. In three studies
women only were included [23,27,31] and in one study
gender of participants was not reported [24]. The mean
age of patients ranged from 38.1 years to 62.6 years.
The use of anti rheumatic drugs and analgesics was
described in eight studies [14,23-28,31]. In six studies
[14,22,24,25,27,31] patients were excluded because of se-
vere cardio-pulmonary disease, or because they used a
walking aid [27].
In three studies [14,24,31] participants with comorbid-
ity other than cardiopulmonary disease were excluded.
One study used a body mass index above 30 as an exclu-
sion criterion [25] and exercising regularly was an exclu-
sion criterion in another study [27]. Characteristics of
patients and controls, disease parameters and results on
aerobic capacity are presented in Table 1. Characteristics
of patients and controls, disease parameters and results
on EE and PA are presented in Table 2.
Physical activity energy expenditure
PA is defined as: “Any bodily movement produced by
skeletal muscles that results in a substantial energy ex-
penditure (EE)” [34]. EE is defined as energy expended
during physical activity and measured in calories or
joules per unit of time [35]. Physical activity energy
expenditure (PAEE) can be calculated using the follow-
ing equation: PAEE =TEE − REE –TEF, wherein TEE
stands for Total EE, REE for resting EE and TEF stands
for the thermal effect of food [35]. Three studies that
measured REE, by indirect calorimetry, described similar
values of REE in patients with RA and healthy controls
[25-27], even when results were adjusted for body cell
mass and weight [27]. However, when results were
adjusted for percentage body fat, REE was higher in per-
sons with RA compared to controls [25,26]. To calculate
PAEE TEE was measured, using the doubly labeled water
technique (DLW) in one study [27]. In the same study
PAEE was estimated using a PA questionnaire and a PA
monitor. Using these three forms of measurement PAEE
was found to be significantly lower in persons with RA
compared to controls. Results from the calculated PAEE
correlated with results obtained with the PA monitor
(r = 0.37) but not with the PA questionnaire.
Aerobic capacity
Aerobic capacity was examined in five studies. Two
studies conducted a maximal treadmill test [22,24]. A
maximal bicycle test was performed in two studies [23,25]
and one study used a sub-maximal bicycle test [28].
Both treadmill studies measured oxygen uptake using
the breath-by-breath method. Neither study reported sig-
nificant differences in aerobic capacity between patientsand controls. One study used an incremental loading
protocol to measure VO2 at every stage of the treadmill
test [22], until predicted maximal heart rate (HRmax) was
reached (220 beats/min – age). Patients and controls were
compared at the end of the last stage to determine
VO2max. However, 50%, 60% and 100% of patients of FC I,
II and III respectively, dropped out before reaching the
final stage of the test, compared to 5% of the healthy con-
trols. EE at sub-maximal levels was higher in patients of
FC II than in the control group, a difference that was not
found when comparing patients of FC I with the control
group. No statistical test was applied to detect differences
between FC III and controls due to the small number of
patients of FC III. The other treadmill study [24] used the
Bruce protocol. The test was continued until voluntary
exhaustion, no criteria for reaching VO2max were given.
VO2max did not differ significantly between patients and
controls, but this study had inadequate sample size.
Two studies conducted a graded bicycIe test [23,25].
In the first study the test was continued until voluntary
exhaustion, however, no criteria for reaching VO2max
were given [23]. Patients with early RA (mean disease
duration 2.9 years) or long-term RA (mean disease dur-
ation 14.5 years) were compared with active healthy
peers. At the end of the test mean HRpeak of participants
fell within 5% of predicted HRmax and no significant dif-
ferences between VO2 max of early RA (ERA), long-term
RA (LRA) or control group were found. In the other
study [25] VO2max was defined as reaching one of the fol-
lowing three criteria: a plateau in oxygen uptake during
the final stage of the test, respiratory exchange ratio > 1.0,
or HRmax within 10% of expected goal. Patients with RA
(mean age 41.8 years) were compared to groups of young
and elderly controls. Persons with RA had a lower mean
VO2max compared to the young controls (mean age 25.8
years), whereas VO2max of patients and elderly controls
(mean age 69.5 years) did not differ significantly.
Finally, VO2max was predicted using a submaximal
Åstrand protocol during a bicycle test in one study [28].
Participants were divided in two categories (younger and
older than 54 years) and bicycle test results were com-
pared between males or females with RA and healthy
controls. Persons with RA had lower estimated VO2max
compared to healthy control groups. Females had lower
estimated VO2max than males and estimated VO2max
decreased with age in all participants.
When comparing VO2max levels of patients with RA to
published normative values [18], results showed that
patients in all studies scored below the 10th percentile.
Physical activity level
Six studies used questionnaires to assess PA level, focus-
ing on different aspects of PA [13,14,26,29-31]. Classify-
ing PA based on levels of intensity was done in two
Table 1 Studies comparing level of aerobic capacity in RA patients and a healthy reference population
Study (ref nr) n (% F) Reference
Population
n (% F)
Patient characteristics VO2max RA patients versus reference population
(ml/kg.min) p: significant difference










47,85 (8,29) ? 8 FCI: 40%
FCII: 51%
FCIII: 8.6%
FC I: 24.89 (n=7)





67 (62.7%) 77♥ (61.0%)
personnel
? 53.0 (10.2) female: 164.1 (5.6) cm
female: 66.1 (11.6) kg
male: 177.9 (6.8) cm
male: 75.6 (10.7 kg
10.6 (7.8) FCII female younger than 54
jr: 22.3±6.8 / 31.7±12.1
older than 54 jr: 18.7±3.5/
21.9±5.3 male younger
than 54 jr: 24.0±4.3/
27.6±7.4 older than 54









Hospital ERA: 41 (9)
LRA: 49 (7)
ERA: 165 (9) cm 61
(13) kg fat: 30.4 (6.6) %
LRA: 164 (7) cm 65
(13) kg fat: 34.3 (7.3) %
ERA: 2.9 (0.6)
LRA: 14.5 (4.5)






19 (100%) 15♥ (100%) ? Rehabilitation
centre
48.3 (8.4) ? 128.8 (85.6)
months
FCI, II 23.7±4.9 / 26.6±6.0 NS
Rall 1996
MB [25]












65.9 (15.9) kg BMI:
25.0 (4.3)
14.6 (12.5) FC: 2.2 (0.8) 22.9±4.2 / young exercise
group: 40.2±10.3 old
exercise group: 20.7±5.0 old




Age, body composition, disease duration are expressed as mean (standard deviation) if not expressed otherwise, VO2max is expressed as mean ± standard deviation. Age and disease duration are expressed in years.
n: number of participants with RA or in reference population, MB: maximal bicycle test, MT: maximal treadmill test, SMB: sub-maximal bicycle test, %F: percentage females, FC: Functional Class, GP: general population,






















Table 2 Studies comparing level of physical activity in RA patients and a healthy reference population
Study
(ref nr)
n (% F) Reference
populationn (%F)
Patients with RA Physical activity RA patiënts versus reference population
p: significant difference










Hospital based 62.6 (9.2) 45–64
jr: 58% > 65
jr: 42%
? ? ? Light: 1297±1009 min/wk /
1495 min/wk Moderate:
369±543 min.wk / 517 min/wk
Vigorous: 170±257 min/wk /
187 min/wk Light: 634±795
min/wk / 618 min/wk Moderate:
231±244 min/wk /304 min/wk






73 (63.0%) 28♦ (57%) ? ? 52.9 (12.9) Fat 36.6 (12.8) %
p<0.001





121 (84%) 120 (91%)
Personnel hospital
Hospital based 49 (19–72) ? 14 (10) ? Walking: 692±610 kcal/w /
1.044±1260 kcal/w Stair
climbing: 184±212 kcal/w /
185±262 kcal/w Exercise:


















20 (100%) 20♣ (100%) ? Arthritis center 47 (14) BMI 25.3 (4.5) 7.7 (6.5) FCI FCII PAEE 2849±1075 kJ/d /
3883±1732 kJ/d PA
questionnaire 2188±1075 kJ/d /
3150±1611 kJ/d PA activity










38.10 (6.62) 1.57 (0.14) m
62.68 (12.56) kg
30 (7,3) FC I: 70% Sedentarism 17.3 % / 3.4%
Mild 57.7% / 35% Moderate
25% / 65% Intense 0% / 0%





23 (82.6) 23◊ (82.6) ? Rheumatology
clinic
50 (15) Body cell mass
22.5 (4.3) kg
p< 0.000
12.3±8.4 jr FC I (n=5)
FC II (n=10)
FC III/IV (n=8)
Vigorous 0.1±0.2 h/d /
1.5±1.5 h/d Moderate
4.0±3.2 h/d / 5.6±2.3 h/d
Light 11.6±3.4 h/d / 9.2±3.2 h/d
p<0.0001 p<0.06
p<0.02
Age, body composition,disease duration and physical activity are expresed as mean±standard deviation if not expressed otherwise. n: number of participants with RA or in reference population, RA: rheumatoid
arthritis, FC: Functional Class, GP: general population, BMI: body mass index in kilogram per square meter, >: older than.
kcal/wk: kilocalory per week, min/wk: minutes per week, kJ/d: kiloJoule per day, h/d: hours per day. Controls matched on ♣: race, age, body mass index, ♠: genetic factors, ♥: age, sex, ◊: race, age, sex, weight,
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intensity of PA undertaken during a normal week,
patients with RA were found to be less engaged in mod-
erate or intense recreational activities or sports [29].
When PA was classified into four levels (sedentary, mild,
moderate or intense activities) [31], patients participated
on a lower intensity level compared to a reference group.
The patients did not engage in regular exercise and were
identified to be 15% more sedentary compared to con-
trols. There was a paucity of information on the instru-
ment used to measure PA.
The Paffenbarger questionnaire [26] was used to meas-
ure hours per day spent in light, moderate or vigorous
forms of PA. PA was defined as walking, stair climbing
and sport and converted into EE per week. In another
study time spent on PA was recorded during one week
using an occupation log consisting of 10 different activ-
ities collapsed into 3 categories: work, activities of daily
living (ADL) and leisure [30]. Results of these studies
[26,30] showed that patients with RA spent an equal
amount of time on PA as controls, but more time on
light activities [26]. When PA was categorized as ADL,
leisure and work, patients spent more time on ADL
while spending less on work [30].
Finally the Short Questionnaire to Assess Health En-
hancing PA (SQUASH) was used to estimate time spent
on light, moderate and vigorous activities in a week [13].
PA was categorized into commuting activities, leisure
time activities, household activities, and activities at
work and school. Results [32] showed that the propor-
tion of patients with RA meeting the public health
recommendation for PA equaled that of the general pub-
lic (58%), nevertheless younger patients (45 – 65 years)
were less active in all categories than controls. Older
patients (> 65 years) showed only a significant decrease
in moderate PA compared to the reference group.
Modified versions of the Paffenbarger Physical Activity
Questionnaire (PPAQ) were used in two trials [14,27] to
calculate PAEE. Though similar proportions of patients
and controls met recommended minimum levels of EE,
patients with RA expended less energy in PA (24.7%),
mainly due to walking less (33.7%) [14]. Roubenoff et al.
[27] found comparable amounts of mean decreased
PAEE in patients with RA (30.5%). Neither studies gave
information on the way the PPAQ was modified and the
consequences for PA assessment.
Discussion
The aim of this study was to review the literature about
physical activity levels and aerobic capacity in patients
with RA, compared to healthy controls and a healthy
reference population.
Few studies were available that compared daily PA of
persons with RA and healthy control groups. Studiesexploring aerobic capacity of persons with RA and
healthy controls were even more scarce. Assessment
methods, inclusion criteria and methodology of match-
ing controls to patient were heterogeneous, complicating
comparisons. No information on the recruitment of con-
trols was available in 50% of the studies and in 25% of
the studies there was no information on the matching of
patients and controls. Selection bias may threaten the
validity of these case–control studies and their results
must be interpreted with caution.
Physical activity energy expenditure
The the gold standard measure to estimate PAEE is
doubly labeled water (DLW) [36]. Only one study used
DLW to assess EE. Roubenoff et al. [27] combined the
use of DLW, a PA monitor and a questionnaire to calcu-
late EE in PA. PAEE and the PA level was significantly
lower in patients than controls, while REE was compar-
able in both groups. EE of patients in this study was com-
parable to normative data [1]. Results of DLW and the
questionnaire did not correlate. This demonstrates a dis-
crepancy between objective and subjective measurement.
Aerobic capacity
Studies using maximal tests reported no significant dif-
ferences in aerobic capacity between persons with RA
and healthy peers, except for one small sized study (n=8)
[25]. Interestingly, in children, adolescents and young
adults with Juvenile Arthritis, there is a large body of lit-
erature suggesting a reduced VO2max in these patients
[37-39].This finding of a comparable aerobic capacity
between patients with RA and healthy controls may be
due to methodological issues, such as criteria for deter-
mining VO2max. The use of secondary criteria of RER ≥
1.10 or 1.15, HRmax ± 10 b/min or blood lactate concen-
tration can either lead to a significant undermeasure-
ment of VO2max or reject participants who have actually
achieved VO2max [40]. The criterium of reaching pre-
dicted HRmax calculated as 220-age has little scientific
basis and can under – or overestimate actual HRmax by
more than 20 beats/min [41]. In a bicycle study VO2max
of patients (mean age 41.8 years) and elderly controls
(mean age 69.5 years) did not differ significantly. As
VO2max declines with age, this means that patients had a
low aerobic capacity. In the study of de Carvalho [22]
HRmax of patients was significantly lower compared to
controls and just reached 90% of predicted HRmax. In
addition, 50%, 60% and 100% of patients of FC I, II and
III respectively, dropped out before reaching the final
stage of the test, whereas only 5% of healthy controls
did, indicating a lower VO2max in RA patients. The other
treadmill study of Kurtais et al. [24] had inadequate
sample size and did not report if participants reached
their HRmax. In patients with LRA HRmax was lower
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within 10% of predicted HRmax in all groups [23]. Rall
et al. [25] did not report if participants met preset
criteria for reaching VO2max.
Small samples combined with large heterogeneity of
participants in lifestyle may have compromised the
power of these studies [42]. Two studies used sedentary
persons as controls [22,24]. Kurtais et al. [24] did not de-
fine sedentary, whereas de Carvalho et al. [22] defined
sedentary as non-exercising. Hakkinen et al. [23]
included physically active controls, but did not define
physically active. When aerobic capacity was predicted
by conducting a sub-maximal bicycle test [28] patients’
VO2max was decreased compared to controls. At baseline
controls exercised more frequently compared to persons
with RA. Results may be biased because sub-maximal
tests of less fit people tend to underestimate observed
values [35]. Moreover, submaximal tests use submaximal
HR during exercise, which is influenced by resting HR.
It is reported that resting HR is significantly higher in
patients with RA [43], but correction for resting HR was
not reported. Minor et al. [44,45] also showed that the
correlation of predicted VO2max and actual VO2max
diminished from 0.96 to 0.77 when a sub-maximal tread-
mill test, validated for use in a healthy population, was
used for testing patients with RA.
Some reviewed studies included patients according to
functional class. In the study that described results for
separate functional classes [22], VO2max decreased from
FCI to FCIII and sub-maximal energy expenditure was
higher in FCII and FCIII compared to FCI and controls.
When VO2max of persons with ERA and LRA was com-
pared, persons with ERA experienced less disability and
had higher VO2max than persons with LRA and controls
[23]. Although no information was available it is plaus-
ible that more persons of higher FC were allocated in
de LRA group.
When comparing patients with RA VO2max values to
published normative data on healthy adults, patients
consistently scored below the 10th percentile, indicating
severe loss of aerobic capacity.
Studies with large, unselected, samples of patients with
RA using rigorous exercise testing protocols and meth-
odology are warranted [18].
Physical activity level
We found 6 studies, using 6 different questionnaires,
limiting comparison across studies. In general it appears
that patients with RA spend more time in light and
moderate activities and less in vigorous activities than
controls. Patients in the trial of de Caravalho et al. [22]
expended significantly more energy than healthy con-
trols, up to 17,9%, especially at normal walking speeds
(3–5 km/h) [22]. Questionnaires using a standardintensity categorization of PA might therefore underesti-
mate energy expenditure of patients with RA. Some
researchers report that one third of persons with RA
experience cachexia [26,46], defined as a loss of muscle
mass combined with higher fat mass and higher REE.
Matching persons with RA and healthy controls on BMI
and comparing EE based on METs may therefore lead to
a biased result [47].
McKinnon et al. [30] found that patients were 20% less
physically active, caused by less time spent on work.
This may be due to the fact that more patients were
unemployed compared to healthy controls: 43% - 86%,
respectively [30]. Tourinho et al. [31] reported similar
differences: 17.3% - 96.7% Patients with RA are at risk to
become unemployed with increasing age and disease
duration [48]. When PA level of persons with RA was
compared to data from the Dutch population patients
were less active. However, employed patients and con-
trols showed comparable levels of PA (2577 min/wk vs
2433 min/wk) [13]. Mancuso et al. [14] found a
decreased EE of 24.7% in patients compared to controls,
even though all participants were employed at the start
of the trial. Differences in results compared to other
studies may have occurred because time spent at work is
not assessed in the Paffenbarger Index.
Reduced vigorous activities and low VO2max in
patients with RA will place these patients at even greater
risk for the metabolic syndrome and thus cardiovascular
disease. We recommend counseling these patients on
the benefits of exercise and doing research on the effect
of (increased) exercise on CVD risk. Further research
into factors that predict higher levels of PA in this popu-
lation is to be recommended.
Conclusion
According to the gold standard persons with RA were
less active compared to healthy subjects. The results of
this review cannot support or refute a conclusion that
persons with RA have decreased aerobic capacity com-
pared to healthy controls. This may reflect the fact that
half the general population is inactive. However, when
compared to normative values patients as well as con-
trols had very low percentile rank of aerobic capacity.
In general it appears that patients with RA spend more
time in light and moderate activities and less in vigorous
activities than controls. A higher functional class seems
to be related to higher sub-maximal EE and lower levels
of PA and aerobic capacity. Unemployment, possibly
related to RA impairment, seems to contribute to a
diminished physical activity level. Patients with RA suf-
fer a 60% greater risk of CVD. Whether this risk can be
reduced by a moderately high or high aerobic capacity
as in healthy subjects, should be a research priority. Im-
proving aerobic capacity in patients with RA seems of
Munsterman et al. BMC Musculoskeletal Disorders 2012, 13:202 Page 9 of 10
http://www.biomedcentral.com/1471-2474/13/202the highest importance and vigorous physical activity
can contribute to this. Aerobic training in stable RA has
been shown to be safe [11] and improve aerobic capacity
[49]. Future research should employ rigorous exercise
testing protocols and methodology including the use
of criteria for reaching VO2max, differentiate between
patients of different functional classes and take employ-
ment status into account.
Competing interests
The authors have declared no conflicts of interest.
Authors’ contributions
TM: made substantial contributions to conception and design, acquisition of
data, analysis and interpretation of data and drafting the manuscript. TT:
revised the paper critically for important intellectual content; and gave final
approval of the version to be published. HW: made substantial contributions
to conception and design, analysis and interpretation of data, revised the
paper critically for important intellectual content; and gave final approval of
the version to be published. All authors read and approved the final
manuscript.
Author details
1Physical Therapy Center, Martini Hospital Groningen, P.O. Box 30033, 9700
RM Groningen, Netherlands. 2School of Clinical Health Sciences, Department
of Physical Therapy Science, Utrecht University, Utrecht, the Netherlands.
3Child Development & Exercise Center, Wilhelmina Children's Hospital,
University Medical Center Utrecht, Utrecht, The Netherlands. 4Research group
Lifestyle and Health, Faculty of Health Care, Utrecht University of Applied
Sciences, Bolognalaan 101, 3584 CJ Utrecht, The Netherlands.
Received: 29 November 2011 Accepted: 10 October 2012
Published: 18 October 2012
References
1. Plasqui G: The role of physical activity in rheumatoid arthritis. Physiol
Behav 2008, 94:270–275.
2. van der Heijde D: Impact of rheumatoid arthritis on physical function
during the first five years. No longer a question mark? Rheumatology (UK)
2000, 39:579–580.
3. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al:
EULAR evidence-based recommendations for cardiovascular risk
management in patients with rheumatoid arthritis and other forms of
inflammatory arthritis. Ann Rheum Dis 2010, 69:325–331.
4. Turesson C, Jacobsson LT, Matteson EL: Cardiovascular co-morbidity in
rheumatic diseases. Vasc Health Risk Manag 2008, 4:605–614.
5. Mayoux-Benhamou A, Giraudet-Le Quintrec JS, Ravaud P, Champion K,
Dernis E, Zerkak D, et al: Influence of patient education on exercise
compliance in rheumatoid arthritis: a prospective 12-month randomized
controlled trial. J Rheumatol 2008, 35:216–223.
6. Giles JT, Bartlett SJ, Andersen RE, Fontaine KR, Bathon JM: Association of
body composition with disability in rheumatoid arthritis: impact of
appendicular fat and lean tissue mass. Arthritis Rheum 2008, 59:1407–1415.
7. Elkan AC, Hakansson N, Frostegard J, Cederholm T, Hafstrom I: Rheumatoid
cachexia is associated with dyslipidemia and low levels of
atheroprotective natural antibodies against phosphorylcholine but not
with dietary fat in patients with rheumatoid arthritis: a cross-sectional
study. Arthritis Res Ther 2009, 11:R37.
8. Metsios GS, Stavropoulos-Kalinoglou A, Sandoo A, van Zanten JJ, Toms TE,
John H, et al: Vascular function and inflammation in rheumatoid arthritis:
the role of physical activity. Open Cardiovasc Med J 2010, 4:89–96.
9. Elkan AC, Hakansson N, Frostegard J, Hafstrom I: Low level of physical
activity in women with rheumatoid arthritis is associated with
cardiovascular risk factors but not with body fat mass - a cross sectional
study. BMC Musculoskelet Disord 2011, 12:13.
10. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Wilson M, Nevill AM,
Koutedakis Y, et al: Association of physical inactivity with increased
cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc
Prev Rehabil 2009, 16:188–194.11. Baillet A, Zeboulon N, Gossec L, Combescure C, Bodin LA, Juvin R, et al:
Efficacy of cardiorespiratory aerobic exercise in rheumatoid arthritis:
meta-analysis of randomized controlled trials. Arthritis Care Res (Hoboken )
2010, 62:984–992.
12. Eurenius E, Stenstrom CH: Physical activity, physical fitness, and general
health perception among individuals with rheumatoid arthritis. Arthritis
Rheum 2005, 53:48–55.
13. van den Berg MH, de Boer I, le CS, Breedveld FC, Vliet Vlieland TP: Are
patients with rheumatoid arthritis less physically active than the general
population? J Clin Rheumatol 2007, 13:181–186.
14. Mancuso CA, Rincon M, Sayles W, Paget SA: Comparison of energy
expenditure from lifestyle physical activities between patients with
rheumatoid arthritis and healthy controls. Arthritis Rheum 2007,
57:672–678.
15. Sokka T, Hakkinen A, Kautiainen H, Maillefert JF, Toloza S, Mork HT, et al:
Physical inactivity in patients with rheumatoid arthritis: data from
twenty-one countries in a cross-sectional, international study. Arthritis
Rheum 2008, 59:42–50.
16. Tierney M, Fraser A, Kennedy N: Physical Activity in Rheumatoid Arthritis:
A Systematic Review. J Phys Act Health 2011, .
17. Chang CL, Chiu CM, Hung SY, Lee SH, Lee CS, Huang CM, et al: The
relationship between quality of life and aerobic fitness in patients with
rheumatoid arthritis. Clin Rheumatol 2009, 28:685–691.
18. Gibbons RJ, Balady GJ, Beasley JW, FAAFP JW, Bricker JT, Duvernoy WFC,
et al: ACC/AHA Guidelines for Exercise Testing: Executive Summary: A
Report of the American College of Cardiology/ American Heart
Association Task Force on Practice Guidelines (Committee on Exercise
Testing). Circulation 1997, 96:345–354.
19. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F:
Evaluating non-randomised intervention studies. Health Technol Assess
2003, 7.
20. Mallen C, Peat G, Croft P: Quality assessment of observational studies
is not commonplace in systematic reviews. J Clin Epidemiol 2006,
59:765–769.
21. West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, et al: Systems to
rate the strength of scientific evidence. Evid Rep Technol Assess (Summ )
2002, :1–11.
22. de Carvalho MR, Tebexreni AS, Salles CA, Barros NT, Natour J: Oxygen
uptake during walking in patients with rheumatoid arthritis–a controlled
study. J Rheumatol 2004, 31:655–662.
23. Hakkinen A, Haanonan P, Nyman K, Hakkinen K: Aerobic and
neuromuscular performance capacity of physically active females with
early or long-term rheumatoid arthritis compared to matched healthy
women. Scand J Rheumatol 2002, 31:345–350.
24. Kurtais Y, Tur BS, Elhan AH, Erdogan MF, Yalcin P:
Hypothalamic-pituitary-adrenal hormonal responses to exercise
stress test in patients with rheumatoid arthritis compared to healthy
controls. J Rheumatol 2006, 33:1530–1537.
25. Rall LC, Meydani SN, Kehayias JJ, wson-Hughes B, Roubenoff R: The effect
of progressive resistance training in rheumatoid arthritis. Increased
strength without changes in energy balance or body composition.
Arthritis Rheum 1996, 39:415–426.
26. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H,
wson-Hughes B, et al: Rheumatoid cachexia: cytokine-driven
hypermetabolism accompanying reduced body cell mass in
chronic inflammation. J Clin Invest 1994, 93:2379–2386.
27. Roubenoff R, Walsmith J, Lundgren N, Snydman L, Dolnikowski GJ,
Roberts S: Low physical activity reduces total energy expenditure in
women with rheumatoid arthritis: implications for dietary intake
recommendations. American Journal of Clinical Nutrition 2002, 76:774–779.
28. Ekdahl C, Broman G: Muscle strength, endurance, and aerobic capacity
in rheumatoid arthritis: a comparative study with healthy subjects.
Ann Rheum Dis 1992, 51:35–40.
29. Lemmey A, Maddison P, Breslin A, Cassar P, Hasso N, McCann R, et al:
Association between insulin-like growth factor status and physical
activity levels in rheumatoid arthritis. J Rheumatol 2001, 28:29–34.
30. MacKinnon JR, Miller WC: Rheumatoid Arthritis and Self Esteem: The
Impact of Quality Occupation. J Occupational Sc 2003, 10:90–98.
31. Tourinho TF, Capp E, Brenol JC, Stein A: Physical activity prevents bone
loss in premenopausal women with rheumatoid arthritis: A cohort study.
Rheumatol Int 2008, 28:1001–1007.
Munsterman et al. BMC Musculoskeletal Disorders 2012, 13:202 Page 10 of 10
http://www.biomedcentral.com/1471-2474/13/20232. Arnett FC, Hunder GG, et al: The American Rheumatism Associatio 1987
revised criteria for the classification of rheumatoid arthritis. Arthritis &
Rheum 1988, 31:315–324.
33. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F: The
American College of Rheumatology 1991 revised criteria for the
classification of global functional status in rheumatoid arthritis.
Arthritis Rheum 1992, 35:498–502.
34. Caspersen CJ, Powell KE, Christenson GM: Physical activity, exercise, and
physical fitness: definitions and distinctions for health-related research.
Public Health Rep 1985, 100:126–131.
35. McArdle WD, Katch FI, Katch VL: Exercise physiology, sixth edition edn.
Lippincott: Williams & Wilkins; 2007.
36. Pols MA, Peeters PH, Kemper HC, Grobbee DE: Methodological aspects of
physical activity assessment in epidemiological studies. Eur J Epidemiol
1998, 14:63–70.
37. Takken T, Hemel A, van der NJ, Helders PJ: Aerobic fitness in children with
juvenile idiopathic arthritis: a systematic review. J Rheumatol 2002,
29:2643–2647.
38. Lelieveld OT, van BM, Takken T, van WE, Van Leeuwen MA, Armbrust W:
Aerobic and anaerobic exercise capacity in adolescents with juvenile
idiopathic arthritis. Arthritis Rheum 2007, 57:898–904.
39. van Brussel M, Lelieveld OT, van der Net J, Engelbert RH, Helders PJ,
Takken T: Aerobic and anaerobic exercise capacity in children with
juvenile idiopathic arthritis. Arthritis Rheum 2007, 57:891–897.
40. Poole DC, Wilkerson DP, Jones AM: Validity of criteria for establishing
maximal O2 uptake during ramp exercise tests. Eur J Appl Physiol 2008,
102:403–410.
41. Robergs RA, Landwehr R: The surprising history of the "HRmax=220-age"
equation. JEPonline 2002, 5.
42. Portney LG, Watkins MP: foundations of clinical research, applications to
practice, second edition edn. Prentice Hall: Health; 2000.
43. Piha SJ, Voipio-Pulkki LM: Elevated resting heart rate in rheumatoid
arthritis: possible role of physical deconditioning. Br J Rheumatol 1993,
32:212–215.
44. Ebbeling CB, Ward A, Puleo EM, Widrick J, Rippe JM: Development of a
single-stage submaximal treadmill walking test. Med Sci Sports Exerc 1991,
23:966–973.
45. Minor MA, Johnson JC: Reliability and validity of a submaximal treadmill
test to estimate aerobic capacity in women with rheumatic disease.
J Rheumatol 1996, 23:1517–1523.
46. Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y,
Nevill AM, Panoulas VF, et al: Blockade of tumour necrosis factor-alpha in
rheumatoid arthritis: effects on components of rheumatoid cachexia.
Rheumatology (Oxford) 2007, 46:1824–1827.
47. Byrne NM, Hills AP, Hunter GR, Weinsier RL, Schutz Y: Metabolic equivalent:
one size does not fit all. J Appl Physiol 2005, 99:1112–1119.
48. Geuskens GA, Burdorf A, Hazes JM: Consequences of rheumatoid arthritis
for performance of social roles–a literature review. J Rheumatol 2007,
34:1248–1260.
49. Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC:
Dynamic exercise programs (aerobic capacity and/or muscle strength
training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev
2009, CD006853.
doi:10.1186/1471-2474-13-202
Cite this article as: Munsterman et al.: Are persons with rheumatoid
arthritis deconditioned? A review of physical activity and aerobic
capacity. BMC Musculoskeletal Disorders 2012 13:202.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
